It’s time for Canada to grow up and to purge the defeatist parasitism that sometimes characterizes our policy-making, write Richard Owens and Stephen...
The federal government is proposing dramatic changes to the pricing of new patented medicines in Canada, and it announced in its recent budget...
Canadian courts have occasionally gone along with poor IP judgments; but they have quickly come to their senses, writes Richard Owens. By Richard...
If you don’t know what the PMPRB is, you should — it holds the power of life and death over us, writes Richard...
OTTAWA, ON (Feb. 8, 2018): A little discussed federal government plan to reduce prices for new drugs must be re-examined to consider the impact...
OTTAWA, ON (Jan. 31, 2018): Canadian courts, in particular the Supreme Court of Canada, have in recent years issued intellectual property (IP) judgments that...
The World Health Organization (WHO) is exploring possibly sweeping changes to intellectual property policies in the name of cheaper drug prices, write Richard...
Canadian law is completely clear: diagnostic tests are patentable, writes Munk Senior Fellow Richard Owens in the Financial Post. By Richard Owens, Dec....
Munk Senior Fellow Richard Owens was interviewed by Canadian current affairs podcast Beyond the Headlines for their episode on the North American Free...
Canada’s stance on dropping provisions around intellectual property (IP) in the Trans-Pacific Partnership (TPP) negotiations makes no sense, writes Richard Owens. By Richard Owens,...
